Monoclonal | search
Click here to view Monoclonal news from 60+ newspapers.
Bookmark or Share- Monoclonal antibody treatment can help high-risk patients with COVID-19Mayo Clinic is treating patients with COVID-19 with monoclonal antibody treatments. The Food and Drug Administration (FDA) issued an emergency use authorization to use bamlanivimab and casirivimab-imdevimab to treat confirmed COVID-19 in patients who have mild or moderate symptoms, and at a high-risk of disease progression and hospitalization. The treatments are given in the outpatient […]
- What’s the latest on monoclonal antibody therapies to treat COVID-19?Along with the monoclonal antibody therapies, the FDA has granted emergency use authorization to two oral antiviral pills to treat mild to moderate COVID-19: nirmatrelvir tablets plus ritonavir, known as Paxlovid, and molnupiravir for high-risk patients. In addition, a three-day regimen of remdesivir, an FDA-approved antiviral drug, has been ...
- Study shows immune molecule may play key role in the progression of ALSMonoclonal antibodies are synthesized immune system proteins used as a treatment for a wide range of diseases. "Our findings showed that the antibody treatment against α5 integrin seemed to protect motor function, delay disease progression and increase survival," says Dr. Roemer.
- Mayo Clinic study finds dysfunctional white blood cells linked to ...Although many who have this condition — called monoclonal B-cell lymphocytosis (MBL) — do not experience any symptoms, a new study shows they may have an elevated risk for several health complications, including melanoma, a form of skin cancer.
- Ovarian cancer: New treatments and researchBevacizumab is a monoclonal antibody used with chemotherapy to treat ovarian cancer recurrence by preventing the growth of new blood vessels that tumors need to grow. Researchers are combining bevacizumab with new drugs to improve outcomes. One example is a monoclonal antibody recently approved by the Food and Drug Administration (FDA) called ...
More
